Your browser doesn't support javascript.
loading
The performance and applied value of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Pan, Bo; Zhu, Xingxing; Xie, Qiang.
Afiliação
  • Pan B; Department of Nuclear Medicine, The First Affiliated Hospital of USTC Hefei 230001, Anhui, China.
  • Zhu X; Department of Nuclear Medicine, The First Affiliated Hospital of USTC Hefei 230001, Anhui, China.
  • Xie Q; Department of Nuclear Medicine, The First Affiliated Hospital of USTC Hefei 230001, Anhui, China.
Am J Nucl Med Mol Imaging ; 13(5): 217-224, 2023.
Article em En | MEDLINE | ID: mdl-38023819
ABSTRACT
Waldenstrom macroglobulinemia (WM) is a rare inert B lymphocyte lymphoma and the role of FDG PET/CT imaging in WM has not been well established. This study aimed to evaluate the metabolic status of WM by 18F-FDG PET/CT imaging. We retrospectively analyzed 20 patients who underwent pretherapy 18F-FDG PET-CT scan. All patients were diagnosed by bone marrow aspiration, laboratory examination and clinical symptoms. Bone marrow involvement was identified with 18F-FDG PET/CT imaging in 16 of 20, and the mean SUVmax of bone marrow was 4.06±0.85, Lymph nodes were involved in 8 of 20 patients, and the mean SUVmax of Lymph nodes was 4.07±1.27. Liver and spleen were involved in one case respectively, with SUVmax being 3.6 and 3.3. 1 case of extramedullary infiltration and 1 case of lymphomatous transformation. 18F-FDG PET/CT imaging not only could reveal the metabolic status of lymph nodes, liver, spleen and bone marrow in WM patients, but also evaluate the status of tumor burden which helps to formulate personalized treatment plans.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article